Andrea Markkula
1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer
- 2018
- Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
- 2017
- Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
- The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
- High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
- Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
- 2016
- CYP1A2 - a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
- Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
- 2015
- Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
- Genetic factors, body constitution, and tumor characteristics in relation to breast cancer prognosis